Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced the filing of a provisional patent application in the United States for INM-405 and other unique compositions as cannabinoid-based topical therapies.
Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that its MoneyTrac Technology, Inc. subsidiary has completed the execution of a joint venture partnership agreement with MediaTechnics Corporation’s (OTC: MEDT) BlazeNow Inc. subsidiary.
A recent analysis by Eight Capital, a Toronto-based investment bank, targets the potential Canadian international medical cannabis market at a staggering $142 billion over the next 15 years.
The CBD market is growing expotentially and consequently the founders of MCOA have contructed their business model around the development of industrial hemp-based CBD products.
PotNetwork Holding, Inc. (OTC: POTN) revenues are projected to reach greater than $30 million by FY2019, $16.7 million in FY2018 and $8.4 million this fiscal year, according to SeeThruEquity, LLC.
Liberty Leaf Holdings Ltd.’s (OTCQB: LIBFF) (CSE: LIB) (FSE: HN3P) wholly own subsidiary, North Road Ventures, has abridged its application to Health Canada, detailing its plans to double its cannabis product lines.
For prospective investors, this climb has created an opportunity to capitalize on the most significant evolution of the global currency landscape in decades.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is a biosciences company that has developed delivery technologies to improve absorption of bioactive compounds.
The Canadian government’s plan to push through legalization of marijuana for recreational purposes by mid-2018 figures to deal a serious blow to the existing black market.
There’s an abundance of scientific evidence proving the medical efficacy of CBD, and investors are flooding the space seeking a share of this colossal 700% growth.
Algae Dynamics Corp (OTC: ADYNF) is uniquely positioned to benefit from the upcoming legalization of recreational marijuana in Canada by mid-2018.
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) was among the very first companies to obtain a cannabis production license in that country and has since been working to change the face of medical cannabis—both in Canada and globally.
InMed Pharmaceuticals (CSE: IN) (OTCQB: IMLFF) has created a revolutionary process that is poised to impact the cannabinoid market.
Numerous industries are being impacted. Cultivation and medicine are just a couple of examples, but cannabis is showing a strong presence in the retail, consulting, and consumer sectors.
Legal marijuana sales in North America hit $6.7 billion in 2016 – a 34 percent jump from the previous year, making it the fastest-growing industry on the planet, according to Arcview Market Research’s 2017 report on the marijuana market.
